Anticoagulant Treatment

Articles on this topic

Safety of Dabigatran in the Secondary Prevention of Venous Thromboembolism in Children

The direct thrombin inhibitor dabigatran is used by adult patients, among others, in the…

29. 9. 2020 Source: Anticoagulant Treatment

Which Anticoagulant Treatment Do Patients Prefer?

For patients with atrial fibrillation (AF) for whom anticoagulant therapy is indicated for stroke...

28. 8. 2020 Source: Anticoagulant Treatment

When to Initiate Dabigatran Therapy in Patients with Atrial Fibrillation After First Ischemic Stroke?

After a cardioembolic ischemic stroke (iCMP), approximately 5% of patients experience a…

21. 7. 2020 Source: Anticoagulant Treatment

Effect of Initiation of Warfarin Therapy on the Risk of Ischemic Stroke

Anticoagulant therapy is essential in patients with atrial fibrillation for the prevention of…

17. 7. 2020 Source: Anticoagulant Treatment

Options for Anticoagulant Therapy During Catheter Ablation for Atrial Fibrillation: Safety and Efficiency of Bridging with Dabigatran Compared to Interruption of NOACs

Catheter ablation is an established method for treating supraventricular and ventricular…

23. 6. 2020 Source: Anticoagulant Treatment

lekar_chirurg_vypisuje_zapis_nemocnice_operace

Perioperative Management in Patients with Atrial Fibrillation Treated with NOACs

The recommended procedures for perioperative management in patients using novel oral…

27. 5. 2020 Source: Anticoagulant Treatment

kv_rizika_ekg_fibrilace_sini_kardiologie

Safety and efficacy of dabigatran and other NOACs compared with warfarin in patients with atrial fibrillation –⁠ results of a large long-term prospective study

Anticoagulant therapy is key in the prevention of strokes in patients with atrial…

25. 5. 2020 Source: Anticoagulant Treatment

fibrilace_sini_zaneseni_katetru_kardiologie

The Benefit of Dabigatran Over Warfarin Is Greater in Patients with Atrial Fibrillation and Diabetes Than in Nondiabetics

As early as 2015, an analysis of the results of the RE-LY study in patients with atrial…

24. 4. 2020 Source: Anticoagulant Treatment

Impact of Dabigatran and Warfarin Treatment on the Risk of Acute Kidney Injury in Patients with Atrial Fibrillation

What clinical characteristics in patients with non-valvular atrial fibrillation may indicate a…

23. 4. 2020 Source: Anticoagulant Treatment

Dabigatran as Effective Prevention of VTE Recurrence Also in Patients with Thrombophilia

With increasing positive experience with direct oral anticoagulants, the question arises of…

17. 3. 2020 Source: Anticoagulant Treatment

Safety and Efficacy of Different Antithrombotic Regimens in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention

Patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) or after percutaneous…

13. 3. 2020 Source: Anticoagulant Treatment

Can NOACs 'Compete' with Well-Managed Warfarin Treatment? Retrospective Data from Swedish Registers

The efficacy and safety of new oral anticoagulants (NOACs) in stroke prevention in atrial…

17. 2. 2020 Source: Anticoagulant Treatment

Idarucizumab reverses the anticoagulant effect of dabigatran even in patients with impaired renal function –⁠ clinical practice commentary

Along with the results of a subanalysis of the RE-VERSE AD study, which demonstrated the…

10. 2. 2020 Source: Anticoagulant Treatment

1 2 3

E-courses on this topic

Course detail

Authors: MUDr. Jana Michalcová

Course detail

Authors: MUDr. Tomáš Hauer

Course detail

Authors: MUDr. Martin Šatný

Course detail